Re:NewCell Future Growth

Future criteria checks 2/6

Re:NewCell is forecast to grow earnings and revenue by 82% and 83% per annum respectively. EPS is expected to grow by 82.7% per annum. Return on equity is forecast to be 12.4% in 3 years.

Key information

82.0%

Earnings growth rate

82.7%

EPS growth rate

Chemicals earnings growth27.6%
Revenue growth rate83.0%
Future return on equity12.4%
Analyst coverage

Low

Last updated22 Dec 2023

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0A5U - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251,39813N/AN/A3
12/31/2024682-145N/AN/A3
12/31/2023260-445N/AN/A3
9/30/2023205-401-578-342N/A
6/30/2023124-408-786-355N/A
3/31/202341-371-1,150-398N/A
12/31/202214-300-1,278-398N/A
9/30/20229-290-1,139-329N/A
6/30/20226-213-1,006-263N/A
3/31/20224-168-645-196N/A
12/31/20214-133-430-118N/A
9/30/20212-88-329-78N/A
6/30/20211-80-181-60N/A
3/31/20212-72-146-66N/A
12/31/20201-69-85-52N/A
9/30/20202-60-51-50N/A
12/31/20191-38-32-31N/A
12/31/2018N/A-18-30-19N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0A5U is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 0A5U is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 0A5U is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 0A5U's revenue (83% per year) is forecast to grow faster than the UK market (4.2% per year).

High Growth Revenue: 0A5U's revenue (83% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 0A5U's Return on Equity is forecast to be low in 3 years time (12.4%).


Discover growth companies